Rimexolone

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

Europe

Austria: Vexol; Belgium: Vexolon; Denmark: Vexol; Finland: Vexol; France: Vexol; Germany: Vexol; Greece: Vexol; Ireland: Vexol; Italy: Vexol; Netherlands: Vexol; Portugal: Vexol; Spain: Vexol; Sweden: Vexol; UK: Vexol.

North America

Canada: Vexol; USA: Vexol.

Latin America

Brazil: Vexol; Mexico: Vexol.

Drug combinations

Chemistry

Rimexolone: C~24~H~34~O~3~. Mw: 370.52. (1) Androsta-1,4-dien-3-one, 11-hydroxy-16,17-dimethyl-17-(1-oxopropyl)-, (11β,16α,17β)-; (2) 11β-Hydroxy-16α,17α-dimethyl-17-propionylandrosta-1,4-dien-3-one. CAS-49697-38-3 (1990).

Pharmacologic Category

EENT Preparations; Anti-inflammatory Agents; Corticosteroids. Ophthalmic Corticosteroid. (ATC-Code: H02AB12; S01BA13).

Mechanism of action

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability.

Therapeutic use

Treatment of inflammation after ocular surgery and treatment of anterior uveitis.

Pregnancy and lactiation implications

Unlabeled use

Contraindications

Hypersensitivity to rimexolone or any component of the formulation. Fungal, viral, or untreated pus-forming bacterial ocular infections.

Warnings and precautions

Steroids may mask infection or enhance existing ocular infection. Prolonged use may result in secondary infections due to immunosuppression. Prolonged use may result in glaucoma and injury to optic nerve. Visual defects in acuity and field of vision may occur. Posterior subcapsular cataracts may form after long-term use. Use with caution in presence of glaucoma (steroids increase intraocular pressure). Perforation may occur with topical steroids in diseases which thin cornea or sclera. Steroid use may delay healing after cataract surgery.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart